| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | TEVA PHARMACEUTICAL INDS LTD | 1,831,400 | 84,263,000 | 0.96% | ||
| 102 | Audentes Therapeutics, Inc. | 4,801,638 | 85,517,000 | 0.97% | ||
| 103 | UNITEDHEALTH GROUP INC | 611,800 | 85,652,000 | 0.98% | ||
| 104 | CORVUS PHARMACEUTICALS INC COM | 5,379,349 | 88,490,000 | 1.01% | ||
| 105 | IMPAX LABORATORIES INC | 3,787,500 | 89,764,000 | 1.02% | ||
| 106 | ILLUMINA INC | 495,500 | 90,013,000 | 1.03% | ||
| 107 | NEUROCRINE BIOSCIE COM USD0.001 | 1,815,474 | 91,936,000 | 1.05% | ||
| 108 | ZIMMER BIOMET HLDGS INC | 717,500 | 93,289,000 | 1.06% | ||
| 109 | ARRAY BIOPHARMA INC | 14,179,900 | 95,714,000 | 1.09% | ||
| 110 | HCA HOLDINGS INC | 1,312,200 | 99,242,000 | 1.13% | ||
| 111 | JOHNSON & JOHNSON | 858,000 | 101,356,000 | 1.15% | ||
| 112 | EXPRESS SCRIPTS HLDG CO | 1,451,900 | 102,403,000 | 1.17% | ||
| 113 | ACHILLION PHARMACEUTICALS IN | 13,107,200 | 106,168,000 | 1.21% | ||
| 114 | BIOMARIN PHARMACEUTICAL INC | 1,151,900 | 106,574,000 | 1.21% | ||
| 115 | BRISTOL MYERS SQUIBB CO | 2,187,400 | 117,945,000 | 1.34% | ||
| 116 | PFIZER INC | 3,532,200 | 119,636,000 | 1.36% | ||
| 117 | THERMO FISHER SCIENTIFIC INC | 816,500 | 129,872,000 | 1.48% | ||
| 118 | INTUITIVE SURGICAL INC | 187,800 | 136,123,000 | 1.55% | ||
| 119 | VERTEX PHARMACEUTICALS INC | 1,612,000 | 140,583,000 | 1.60% | ||
| 120 | REGENERON PHARMACEUTICALS | 355,300 | 142,838,000 | 1.63% | ||
| 121 | WELLCARE HEALTH PLANS INC | 1,248,000 | 146,128,000 | 1.66% | ||
| 122 | MOLINA HEALTHCARE INC | 2,634,700 | 153,656,000 | 1.75% | ||
| 123 | IRONWOOD PHARMACEUTICALS INC | 9,949,000 | 157,990,000 | 1.80% | ||
| 124 | GILEAD SCIENCES INC | 2,010,700 | 159,087,000 | 1.81% | ||
| 125 | PUMA BIOTECHNOLOGY | 2,383,525 | 159,815,000 | 1.82% | ||
| 126 | LILLY ELI & CO | 2,040,500 | 163,771,000 | 1.87% | ||
| 127 | EDWARDS LIFESCIENCES CORP | 1,373,200 | 165,553,000 | 1.89% | ||
| 128 | INCYTE CORP | 1,850,178 | 174,453,000 | 1.99% | ||
| 129 | AGILENT TECHNOLOGIES INC | 3,714,800 | 174,930,000 | 1.99% | ||
| 130 | ALLERGAN PLC | 778,690 | 179,340,000 | 2.04% | ||
| 131 | Wright Medical Group NV | 7,356,233 | 180,448,000 | 2.06% | ||
| 132 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,120,000 | 184,341,000 | 2.10% | ||
| 133 | SHIRE PLC | 1,063,351 | 206,141,000 | 2.35% | ||
| 134 | MERCK & CO INC | 3,506,800 | 218,859,000 | 2.49% | ||
| 135 | ABBVIE INC | 4,229,900 | 266,780,000 | 3.04% | ||
| 136 | CELGENE CORP | 2,948,577 | 308,215,000 | 3.51% | ||
| 137 | ALEXION PHARMACEUTIC | 2,638,011 | 323,262,000 | 3.68% | ||
| 138 | AMGEN INC | 2,436,700 | 406,466,000 | 4.63% | ||
| 139 | BOSTON SCIENTIFIC CORP | 17,211,700 | 409,638,000 | 4.67% | ||
| 140 | BIOGEN INC | 1,333,900 | 417,551,000 | 4.76% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-004318, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
